EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Patient Selection and Renal Denervation

Ankita Ashoka, Raven Voora

Current Hypertension Reports · 21.01.2026 · 28 (1)

DOI: 10.1007/s11906-025-01360-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Hypertension Reports, online erschienen am 21.01.2026. Verfasst von Ankita Ashoka und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, NC, 27599, USA. Hauptthemen laut MEDLINE: Patient Selection, Hypertension, Kidney, Sympathectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF REVIEW: To review the current data informing patient selection and provide guidance on when to refer potential patients for consideration of renal denervation. RECENT FINDINGS: Multiple sham-controlled randomized trials have demonstrated favorable safety and efficacy outcomes for renal denervation (RDN) in the management of uncontrolled hypertension in patients across the hypertension (HTN) spectrum including patients with true resistant hypertension (TRH) and in patients both on and off antihypertensive therapy. In addition, sustained reductions in BP up to 3 years have been observed. Based on these favorable findings, guidelines and position papers recommend RDN as an adjunct to antihypertensive medications and lifestyle modifications in patients with uncontrolled hypertension and increased risk of cardiovascular (CV) complications like TRH patients and in patients who are unable or unwilling to optimize medical therapy for uncontrolled hypertension. However, data on RDN safety and efficacy remain limited in chronic kidney disease (CKD) and isolated systolic hypertension (ISH). Another area of active investigation is the identification of predictors of response to RDN which could help refine criteria for patient selection. Selection of patients for RDN requires an evaluation of the hypertension prior to referral in addition to engaging patients in shared decision-making (SDM). It is also recommended that patients being considered for RDN be evaluated by a multidisciplinary team who is knowledgeable about hypertension and RDN. RDN is an adjunct to lifestyle modification and medications for the treatment of hypertension. Appropriate patient selection for RDN is based on populations studied in clinical trials and should include a comprehensive evaluation of the uncontrolled hypertension prior to referral.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient SelectionHypertensionKidneySympathectomyHumansAntihypertensive AgentsBlood Pressure

Stichwörter der Autor:innen

Chronic kidney diseaseIsolated systolic hypertensionPatient selectionRenal denervationResistant hypertensionShared decision-making

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, NC, 27599, USA.
  • Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, NC, 27599, USA. raven_voora@med.unc.edu.
  • UNC Kidney Center, CB 7156, Division of Nephrology, CB 7155, 7022 Burnett Womack, Chapel Hill, NC, 27599-7156, USA. raven_voora@med.unc.edu.

Zitieren

APA

Ashoka, A., & Voora, R. (2026). Patient Selection and Renal Denervation. Current Hypertension Reports, 28(1). https://doi.org/10.1007/s11906-025-01360-5

Vancouver

Ashoka A, Voora R. Patient Selection and Renal Denervation. Current Hypertension Reports. 2026;28(1). doi:10.1007/s11906-025-01360-5

BibTeX
@article{Ashoka2026,
  author = {Ashoka, Ankita and Voora, Raven},
  title = {Patient Selection and Renal Denervation},
  journal = {Current Hypertension Reports},
  year = {2026},
  volume = {28},
  number = {1},
  doi = {10.1007/s11906-025-01360-5}
}
Kostenlos starten →